Pantelis Natsiavas

Semmelweis University — Hungary

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

14h-index1.2kcitations92works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacovigilance and Adverse Drug Reactions(17), Biomedical Text Mining and Ontologies(15), Mobile Health and mHealth Applications(12), Biosimilars and Bioanalytical Methods(11), Computational Drug Discovery Methods(9)

Publications91 total

Changes in use and utilisation patterns of drugs with reported shortages between 2010 and 2024 in Europe and North America: a network cohort study
The Lancet Public Health·2025· 1 citedOpen Access
Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled Trial
JCO Oncology Practice·2025
PEDRO: A Peer-to-Peer Support Platform for Adverse Drug Reaction Management in Patients with CLL
Studies in health technology and informatics·2025Open Access
Designing a children’s health exposomics study protocol: The CHILDREN_FIRST multi-country prospective cohort using multi-omics and personalized prevention approaches
2025Open Access
Preliminary Results of an OMOP-CDM Based Characterization Study for Rhabdomyolysis in Greece
Studies in health technology and informatics·2025Open Access
Preface
Pure Amsterdam UMC·2025
Exploring Telemedicine Acceptance: Applying the COM-B Model to Understand Cancer Patients’ Perspectives
Studies in health technology and informatics·2025· 1 citedOpen Access
Preface
Pure Amsterdam UMC·2025
Enhancing Healthcare Professionals’ Adherence to the MyPal Project Digital Health Intervention Protocol Through Quick Reference Guides
Studies in health technology and informatics·2025Open Access
Reliable machine learning models in genomic medicine using conformal prediction
Frontiers in Bioinformatics·2025· 2 citedOpen Access
OpenPVSignal Knowledge Graph: Pharmacovigilance Signal Reports in a Computationally Exploitable FAIR Representation
Drug Safety·2025· 3 citedOpen Access
Usability and User Experience Testing of a Co-Designed Electronic Patient-Reported Outcomes App (“MyPal for Adults”) for Palliative Cancer Care: Mixed Methods Study
JMIR Human Factors·2025· 4 citedOpen Access
The smartHEALTH European Digital Innovation Hub experiences and challenges for accelerating the transformation of public and private organizations within the innovation ecosystem
Frontiers in Medicine·2024· 4 citedOpen Access
Editorial: AI/ML in pharmacovigilance and pharmacoepidemiology
Frontiers in Drug Safety and Regulation·2024· 2 citedOpen Access
Improving Quality of Life Based on Electronic Patient Reported Outcomes in Patients with CLL and MDS: The Mypal Study
Blood·2024
Applying AI to Structured Real-World Data for Pharmacovigilance Purposes: Scoping Review
Journal of Medical Internet Research·2024· 20 citedOpen Access
Reliable machine learning models in genomic medicine using conformal prediction
2024Open Access
Trends of use of drugs with suggested shortages and their alternatives across 52 real world data sources and 18 countries in Europe and North America
2024· 2 citedOpen Access
Mapping OMOP-CDM to RDF: Bringing Real-World-Data to the Semantic Web Realm
Studies in health technology and informatics·2024· 2 citedOpen Access
Exploring User Views on Telemedicine to Support Cancer Patients: Insights from Focus Group Discussions in the Context of the eCAN Joint Action
Studies in health technology and informatics·2024Open Access
page 1 of 5Next →

Frequent Co-authors

Nicos Maglaveras(12), Vassilis Koutkias(11), Ioanna Chouvarda(9), Christine Kakalou(9), Dimitrios Tzovaras(8), Vlasios K. Dimitriadis(8), Konstantinos Votis(7), Marie‐Christine Jaulent(7), Christina Karamanidou(6), Eleni Kazantzaki(5), Stella Dimitsaki(5), George Gavriilidis(5), Marco Nalin(4), Giuliana Faiella(4), Jos Dumortier(4), Sheila Payne(4), Vassilis Kilintzis(4), Panos Bonotis(4), Achilleas Chytas(4), Dimitris Filos(3)